Management ChangeJun 24, 2026, 08:32 AM
Bionano Genomics Appoints Alex Hastie as Chief Scientific Officer
AI Summary
Bionano Genomics, Inc. announced the appointment of Alex Hastie, Ph.D. as its new Chief Scientific Officer, effective July 20, 2026. Dr. Hastie, who previously spent 14 years at Bionano as a foundational figure in its scientific evolution, will lead the company's global scientific strategy, innovation roadmap, and research initiatives. His return is expected to strengthen Bionano's commitment to expanding the research application of its genome analysis technologies and developing clinical applications, receiving overwhelmingly positive responses from the scientific community.
Key Highlights
- Bionano Genomics appointed Alex Hastie, Ph.D. as its Chief Scientific Officer (CSO).
- Dr. Hastie's appointment is effective July 20, 2026.
- He will lead the company's global scientific strategy, innovation roadmap, and research initiatives.
- Dr. Hastie previously spent 14 years at Bionano, playing a key role in developing its core technologies.
- His role includes expanding research applications of genome analysis technologies and developing clinical applications.
Price Impact
More from BNGO